Author:
Louis W. J.,Drummer O. H.,Tung L.-H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference23 articles.
1. Louis WJ, McNeil JJ, Drummer OH. Labetalol and other vasodilator-beta blocking drugs. In: Doyle AE, ed. Handbook of hypertension, clinical pharmacology of antihypertensive drugs. Elsevier Press, in press, 1988.
2. McNeil JJ, Louis WJ. Clinical Pharmacokinetics of labetalol. Clin Pharmacokin 1984;9:157?167.
3. Cambridge D, Allan G, Hardy GW, et al. Pharmacological profile in vivo of a novel angiotensin converting enzyme inhibitor and beta blocker. Proc 11th Scientific Meeting of the International Society of Hypertension, Heidelberg, FRG, p. 26.
4. Allan G, Cambridge D, Hardy GW. BW A575C, a novel antihypertensive agent with angiotensin converting enzyme inhibition and beta blocking properties. Br J Pharmacol 1986;89:488p.
5. Brittain RT, Drew BM, Levy GP. The alpha-and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. Br J Pharmacol 1982;77:105.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Celiprolol;Cardiology in Review;2017-09
2. Do partial agonist beta-blockers have improved clinical utility?;Cardiovascular Drugs and Therapy;1993-06